By contrast, we have used these datasets to confirm the prognostic utility of the lncRNA SChLAP1 in prostate cancer, and high expression of SChLAP1 is a powerful predictor for poor patient survival (Fig. 1E) [4]. Here, SCHLAP1 is linked to Familial prostate cancer.